During the past decade, Ente Ospedaliero Ospedali Galliera; S.C. Oncologia Medica conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ente Ospedaliero Ospedali Galliera; S.C. Oncologia Medica" #1 collaborator was "Istituto Di Ricerche Farmacologiche Mario Negri" with 2 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Federation of Italian Cooperative Oncology Groups" with 1 trials as a collaborator, "Fondazione Policlinico Universitario Agostino Gemelli IRCCS" with 1 trials as a collaborator and "Fondazione Umberto Veronesi" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Ente Ospedaliero Ospedali Galliera; S.C. Oncologia Medica" are "Breast Cancer" (2 trials), "Lung Cancer" (2 trials), "Ovarian Cancer" (2 trials), "Breast Neoplasms" (1 trials) and "Carcinoma, Ovarian Epithelial" (1 trials). Many other conditions were trialed in "Ente Ospedaliero Ospedali Galliera; S.C. Oncologia Medica" in a lesser frequency.

Most popular intervention types in "Ente Ospedaliero Ospedali Galliera; S.C. Oncologia Medica" are "Drug" (10 trials), "Biological" (1 trials), "Dietary Supplement" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Pertuzumab" (3 trials), "Placebo" (3 trials), "Docetaxel" (2 trials), "Paclitaxel" (2 trials) and "Trastuzumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ente Ospedaliero Ospedali Galliera; S.C. Oncologia Medica" are 7 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Ente Ospedaliero Ospedali Galliera; S.C. Oncologia Medica". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ente Ospedaliero Ospedali Galliera; S.C. Oncologia Medica, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ente Ospedaliero Ospedali Galliera; S.C. Oncologia Medica, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".